Lumbosacral radiculoplexus neuropathy (LRPN), a painful, paralytic, immune-mediated neuropathy, is associated with increased mortality risk, likely due to higher frequency of diabetes mellitus and other comorbidities in these patients, according to study results published in Neurology.
The frequency of LRPN is significantly higher among patients with diabetes mellitus, and LRPN can be divided into diabetic and non-diabetic LRPN. The objective of the current population-based study was to explore the outcomes and survival of patients with LRPN.
Using data the facilities of the Rochester Epidemiology Project, study researchers identified all potential cases of LRPN from early 2000 through the end of 2015 in Olmsted County, Minnesota.
The study sample included 59 (median age, 70 years; 56% men) patients with 62 LRPN episodes, including 39 patients with diabetes mellitus. At the time of diagnosis, pain and/or weakness were reported in over 90% of episodes, and the disease was bilateral in more than a third of episodes (37.1%).
Median Neuropathy Impairment Score (NIS) improved over the course of the follow-up from 20 points at baseline to 17 points (P =.0002), and most patients (55.6%) had an improvement of at least 4 points. Similarly, median modified Rankin scale score improved from 3 at baseline to 2 at the end of follow-up.
While the survival rates were significantly lower for patients with LRPN, compared with age- and gender matched controls (median survival, 12.2 vs ≥17 years, respectively; P =0.0182), there were no fatality cases directly related to the LRPN. The probability of survival in patients with LRPN was 86% at 5 years and 55% at 10 years. Patients with LRPN had a 76% increased mortality risk compared with age- and gender-matched controls (P = .0164).
Multivariate Cox-proportional hazard models for mortality risk factors showed that diabetes mellitus, age, and stroke were mortality risk factors in 3 different models, while chronic kidney disease, coronary artery disease and peripheral vascular disease were associated with increased mortality risk in 2 models. However, an LRPN episode was not an independent mortality risk factor in the multivariate analysis.
“LRPN is self-limited inflammatory neuropathy that improves over time but often leaves people with problematic functional impairment and ongoing need for walking aids. Although having LRPN increases mortality risk, this increased mortality is probably due to higher prevalence of [diabetes mellitus] and other comorbidities rather than to the LRPN itself,” concluded the study researchers.
Pinto MV, Ng PS, Howe BM, et al. Lumbosacral radiculoplexus neuropathy: neurological outcomes and survival in a population-based study. Neurology. Published online March 2, 2021. doi:10.1212/WNL.0000000000011799
This article originally appeared on Neurology Advisor